IRIS
PLATANIA, CHIARA BIANCA MARIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.982
EU - Europa 1.796
AS - Asia 1.522
AF - Africa 298
SA - Sud America 247
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 6.852
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.900
SG - Singapore 795
RU - Federazione Russa 633
IT - Italia 591
CN - Cina 455
BR - Brasile 215
IE - Irlanda 201
CI - Costa d'Avorio 182
UA - Ucraina 87
DE - Germania 74
VN - Vietnam 71
SN - Senegal 70
KR - Corea 64
CA - Canada 52
GB - Regno Unito 46
IN - India 33
SE - Svezia 32
PL - Polonia 26
FI - Finlandia 25
JP - Giappone 23
MX - Messico 21
AR - Argentina 16
ES - Italia 15
NL - Olanda 15
ZA - Sudafrica 15
HK - Hong Kong 14
BD - Bangladesh 12
FR - Francia 12
TR - Turchia 11
BE - Belgio 8
NG - Nigeria 8
BJ - Benin 7
IQ - Iraq 7
CH - Svizzera 6
EC - Ecuador 6
ID - Indonesia 6
KE - Kenya 6
LT - Lituania 6
AE - Emirati Arabi Uniti 5
AT - Austria 5
MA - Marocco 5
CZ - Repubblica Ceca 4
EU - Europa 4
TN - Tunisia 4
UZ - Uzbekistan 4
AU - Australia 3
CO - Colombia 3
GR - Grecia 3
NP - Nepal 3
PK - Pakistan 3
PY - Paraguay 3
AL - Albania 2
AZ - Azerbaigian 2
GT - Guatemala 2
JO - Giordania 2
KG - Kirghizistan 2
LB - Libano 2
BA - Bosnia-Erzegovina 1
BO - Bolivia 1
BY - Bielorussia 1
BZ - Belize 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GD - Grenada 1
GE - Georgia 1
GH - Ghana 1
IL - Israele 1
IM - Isola di Man 1
IR - Iran 1
JM - Giamaica 1
LK - Sri Lanka 1
MD - Moldavia 1
NI - Nicaragua 1
OM - Oman 1
PE - Perù 1
SA - Arabia Saudita 1
TT - Trinidad e Tobago 1
VE - Venezuela 1
YE - Yemen 1
Totale 6.852
Salva come PNG Salva come JPEG
Città #
Singapore 495
Santa Clara 438
Dallas 421
Chandler 321
Moscow 270
Dublin 201
Abidjan 182
Catania 179
Chicago 164
Ashburn 163
San Jose 137
Hefei 120
Jacksonville 94
Houston 91
Boardman 82
Beijing 73
Dakar 70
Seoul 61
Los Angeles 59
Cambridge 48
Lawrence 47
Andover 43
New York 36
Civitanova Marche 35
Ho Chi Minh City 28
Toronto 27
Wilmington 27
Des Moines 24
São Paulo 24
Nanjing 23
Rome 23
Bremen 21
Buffalo 20
Orem 20
Seattle 19
Tokyo 19
Warsaw 19
The Dalles 18
Council Bluffs 17
Hanoi 17
Aci Catena 16
Columbus 16
Falls Church 16
Messina 16
Palermo 16
Phoenix 14
Milan 13
Rio de Janeiro 13
Brooklyn 12
Lappeenranta 12
Munich 12
Stockholm 12
Hong Kong 11
Redwood City 11
Atlanta 10
Boydton 10
Changsha 10
Dong Ket 10
Hebei 10
Johannesburg 10
Ottawa 10
Saint Petersburg 10
Shenyang 10
Belo Horizonte 9
Denver 9
Manchester 9
Mexico City 9
Mumbai 9
Naples 9
San Mateo 9
Abuja 8
Grafing 8
Montreal 8
Redmond 8
Redondo Beach 8
Ankara 7
Cotonou 7
Jiaxing 7
Nanchang 7
San Gregorio di Catania 7
Chennai 6
Dearborn 6
Guangzhou 6
London 6
Pozzallo 6
Rosolini 6
Shanghai 6
Boston 5
Brasília 5
Bronte 5
Brussels 5
Cagliari 5
Curitiba 5
Hyderabad 5
Manaus 5
Nairobi 5
San Francisco 5
Turku 5
Washington 5
Amsterdam 4
Totale 4.700
Salva come PNG Salva come JPEG
Nome #
Current drug treatments targeting dopamine D3 receptor 224
Antioxidant and osmoprotecting activity of taurine in dry eye models 179
Caffeine Protects Against Retinal Inflammation 156
Blood-retinal barrier protection against high glucose damage: The role of P2X7 receptor 152
Altered dopamine D3 receptor gene expression in MAM model of schizophrenia is reversed by peripubertal cannabidiol treatment 151
Computational systems biology approach to identify novel pharmacological targets for diabetic retinopathy 148
Innovative Nanoparticles Enhance N-Palmitoylethanolamide Intraocular Delivery 146
Aflibercept regulates retinal inflammation elicited by high glucose via the PlGF/ERK pathway 143
Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells 142
Glucose-impaired Corneal Re-epithelialization Is Promoted by a Novel Derivate of Dimethyl Fumarate 138
Anti-angiogenic and antioxidant effects of axitinib in human retinal endothelial cells: implications in diabetic retinopathy 133
Retinal biomarkers and pharmacological targets for Hermansky-Pudlak syndrome 7 128
Tgf-β serum levels in diabetic retinopathy patients and the role of anti-vegf therapy 127
Controversies in Glaucoma: Current Medical Treatment and Drug Development 126
Effects of topical indomethacin, bromfenac and nepafenac on lipopolysaccharide-induced ocular inflammation 124
1α,25-dihydroxyvitamin D3 protects retinal ganglion cells in glaucomatous mice 122
Drug delivery of synthetic antisense “Bioconjugates” for anticancer therapy DNA. 120
Influence of different surfactants on the technological properties and in vivo ocular tolerability of lipid nanoparticles. 118
Fingolimod and Diabetic Retinopathy: A Drug Repurposing Study 117
Dopamine D-3 receptor as a new pharmacological target for the treatment of depression 117
Novel therapeutics in glaucoma management 115
Topical ocular delivery of TGF-β1 to the back of the eye: Implications in age-related neurodegenerative diseases 114
Dihydrotanshinone, a natural diterpenoid, preserves blood-retinal barrier integrity via p2x7 receptor 114
Retinal pharmacodynamic and pharmacokinetic profile of cannabidiol in an in vivo model of retinal excitotoxicity 112
Retinal protection and distribution of curcumin in vitro and in vivo 112
Blockade of P2X7 receptors preserves blood retinal barrier integrity by modulating the plasmalemma vesicle-associated protein: Implications for diabetic retinopathy 111
Dopamine D3 receptor-dependent changes in alpha6 GABAA subunit expression in striatum modulate anxiety-like behaviour: Responsiveness and tolerance to diazepam 109
Vitamin D3 preserves blood retinal barrier integrity in an in vitro model of diabetic retinopathy 108
P2X7 receptor antagonism: implications in diabetic retinopathy 108
Novel ophthalmic formulation of myriocin: implications in retinitis pigmentosa 108
Assessment of a new nanostructured microemulsion system for ocular delivery of sorafenib to posterior segment of the eye 108
Drug Delivery of Synthetic Antisense-DNA “bioconjugates” for Anticancer Therapy 107
Dopamine D3 receptor is necessary for ethanol consumption: an approach with buspirone 105
Retinal and Circulating miRNAs in Age-Related Macular Degeneration: An In vivo Animal and Human Study 104
New Brilliant Blue G Derivative as Pharmacological Tool in Retinal Surgery 103
Novel indole derivatives targeting HuR-mRNA complex to counteract high glucose damage in retinal endothelial cells 102
Synthesis, in vitro and in silico studies of HO-1 inducers and lung antifibrotic agents 101
Ocular pharmacological profile of hydrocortisone in dry eye disease 101
Homology modeling of dopamine D2 and D3 receptors: molecular dynamics refinement and docking evaluation 100
Do extracellular RNAs provide insight into uveal melanoma biology? 99
Molecular features of interaction between VEGFA and anti-angiogenic drugs used in retinal diseases: a computational approach 99
Circulating miRNAs in diabetic retinopathy patients: Prognostic markers or pharmacological targets? 98
Effects of Vitamin D3 and Meso-Zeaxanthin on Human Retinal Pigmented Epithelial Cells in Three Integrated in vitro Paradigms of Age-Related Macular Degeneration 98
Fortified extract of red berry, Ginkgo biloba, and white willow bark in experimental early diabetic retinopathy 93
Effects of protein-protein interface disruptors at the ligand of the glucocorticoid-induced tumor necrosis factor receptor-related gene (GITR) 92
Integrating network pharmacology: The next-generation approach in ocular drug discovery 91
TGF-β1 prevents rat retinal insult induced by amyloid-β (1–42) oligomers 91
Editorial: Chronic Inflammation and Neurodegeneration in Retinal Disease 87
DRUG DELIVERY OF SYNTHETIC ANTISENSE-DNA "BIOCONJUGATES" FOR ANTICANCER THERAPY 86
In-Silico Characterization of von Willebrand Factor Bound to FVIII 85
Characterization of protein-protein interfaces through a protein contact network approach 83
Resolvin D1 Modulates the Intracellular VEGF-Related miRNAs of Retinal Photoreceptors Challenged With High Glucose 79
Stabilization of HIF-1α in Human Retinal Endothelial Cells Modulates Expression of miRNAs and Proangiogenic Growth Factors 79
MicroRNA target prediction in glaucoma 75
Novel heme oxygenase-1 (Ho-1) inducers based on dimethyl fumarate structure 75
Ocular allergy 74
Molecular basis of alcohol intake: role of D3 dopaminergic receptor 74
Ocular pharmacological and biochemical profiles of 6-thioguanine: a drug repurposing study 70
Implications of dopamine D3 receptor for glaucoma: in-silico and in-vivo studies 66
The Identification of New Pharmacological Targets for the Treatment of Glaucoma: A Network Pharmacology Approach 66
The P2X7 receptor as a new pharmacological target for retinal diseases 64
Molecular Dynamics Simulation Techniques as Tools in Drug Discovery and Pharmacology: A Focus on Allosteric Drugs 58
Erratum: Homology modeling of dopamine D2 and D3 receptors: Molecular dynamics refinement and docking evaluation (PLoS ONE (2013) 8:1 DOI: 10.1371/annotation/bd61cc74-2a2c-4433-a78d-84fa2310e919) 55
Retinal and circulating miRNA expression patterns in diabetic retinopathy: An in silico and in vivo approach. 55
α1D Adrenergic Receptor Antagonism Protects Against High Glucose-Induced Mitochondrial Dysfunction and Blood Retinal Barrier Breakdown in ARPE-19 Cells 54
Ocular Allergies 53
Targeting the miRNA-155/TNFSF10 network restrains inflammatory response in the retina in a mouse model of Alzheimer’s disease 31
Totale 6.983
Salva come PNG Salva come JPEG
Categoria #
all - tutte 22.001
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 22.001
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 0 34 5 19 15 27 20
2021/2022385 31 45 10 6 50 18 64 21 32 6 19 83
2022/2023927 61 66 17 109 121 120 16 170 173 16 31 27
2023/2024403 32 43 18 21 31 115 7 30 1 3 57 45
2024/20251.769 42 254 75 128 373 242 100 56 129 106 152 112
2025/20262.805 243 184 604 251 550 785 188 0 0 0 0 0
Totale 6.983